These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 33479829)

  • 21. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway.
    Xie Y; Yu N; Chen Y; Zhang K; Ma HY; Di Q
    Mol Med Rep; 2017 Aug; 16(2):1691-1700. PubMed ID: 28627626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Immune Tolerance Role of the HMGB1-RAGE Axis.
    Watanabe H; Son M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway.
    Feng L; Zhu M; Zhang M; Jia X; Cheng X; Ding S; Zhu Q
    Int Immunopharmacol; 2013 Feb; 15(2):206-16. PubMed ID: 23219582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen's encephalitis.
    Luan G; Gao Q; Zhai F; Chen Y; Li T
    Epilepsy Res; 2016 Jul; 123():36-49. PubMed ID: 27108105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of High-Mobility Group Box-1 in Liver Pathogenesis.
    Khambu B; Yan S; Huda N; Yin XM
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGB1 and RAGE in inflammation and cancer.
    Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
    Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
    Li K; Yang J; Han X
    Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue.
    Nativel B; Marimoutou M; Thon-Hon VG; Gunasekaran MK; Andries J; Stanislas G; Planesse C; Da Silva CR; Césari M; Iwema T; Gasque P; Viranaicken W
    PLoS One; 2013; 8(9):e76039. PubMed ID: 24073286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of high mobility group protein B1 in periodontal tissues and its association with hepatic lipid metabolism in diabetic rats with periodontitis].
    Pei X; Meng S; Gou C; Du Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):6-12. PubMed ID: 32376562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High mobility group box 1 protein interacts with multiple Toll-like receptors.
    Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
    Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
    Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
    Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
    Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin.
    Zenerino C; Nuzzo AM; Giuffrida D; Biolcati M; Zicari A; Todros T; Rolfo A
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29149067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular insights into the multifaceted functions and therapeutic targeting of high mobility group box 1 in metabolic diseases.
    Tao Z; Helms MN; Leach BCB; Wu X
    J Cell Mol Med; 2022 Jul; 26(14):3809-3815. PubMed ID: 35706377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
    Sohn E; Kim J; Kim CS; Lee YM; Kim JS
    Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target.
    Ngcobo NN; Sibiya NH
    Diab Vasc Dis Res; 2024; 21(5):14791641241271949. PubMed ID: 39271468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
    Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
    Musumeci D; Roviello GN; Montesarchio D
    Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.